SAS Output

21-JUL-2017 18:10

ERLYTX ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1609-Rare Tumor, Comb Nivo/Ipi 1 Y 1 Nivolumab + Ipilimumab 334 111 111 111 87 28 4 01/30/2017 324 132
            111 111 111 87 28 4      
 
Yes A071102-GBM, adj TMZ +/- Veliparib 0 E Total Registrations   110 30 0 0 0 0 02/02/2015 361 161
            110 30 0 0 0 0      
 
    1 E Total Registrations   37 14 0 0 0 0 02/02/2015    
            37 14 0 0 0 0      
 
  A071401-Prog Meningiomas,SMO/AKT/NF2 Inhib 0 E Total Registrations   31 16 9 4 3 1 02/22/2016 234 102
            31 16 9 4 3 1      
 
    1 E Total Registrations   5 1 1 0 0 0 02/22/2016    
            5 1 1 0 0 0      
 
  ARST1321-NonRhabdo STS,Pazopanib (PAZNTIS) 1 E Total Registrations   4 2 2 1 0 0 09/04/2015 254 121
            4 2 2 1 0 0      
 
  EAY131-MATCH 0 E Total Registrations   877 714 326 103 1 1 08/21/2015 436 230
            877 714 326 103 1 1      
 
    1 E Total Registrations   95 92 46 24 2 0 08/21/2015    
            95 92 46 24 2 0      
 
    2 E Total Registrations   5 5 2 1 1 0 08/21/2015    
            5 5 2 1 1 0